» Articles » PMID: 38694819

The Bone Marrow of Mouse-rat Chimeras Contains Progenitors of Multiple Pulmonary Cell Lineages

Overview
Specialty Cell Biology
Date 2024 May 2
PMID 38694819
Authors
Affiliations
Soon will be listed here.
Abstract

Radiation-induced lung injury (RILI) is a common complication of anti-cancer treatments for thoracic and hematologic malignancies. Bone marrow (BM) transplantation restores hematopoietic cell lineages in cancer patients. However, it is ineffective in improving lung repair after RILI due to the paucity of respiratory progenitors in BM transplants. In the present study, we used blastocyst injection to create mouse-rat chimeras, these are artificial animals in which BM is enriched with mouse-derived progenitor cells. FACS-sorted mouse BM cells from mouse-rat chimeras were transplanted into lethally irradiated syngeneic mice, and the contribution of donor cells to the lung tissue was examined using immunostaining and flow cytometry. Donor BM cells provided long-term contributions to all lung-resident hematopoietic cells which includes alveolar macrophages and dendritic cells. Surprisingly, donor BM cells also contributed up to 8% in pulmonary endothelial cells and stromal cells after RILI. To identify respiratory progenitors in donor BM, we performed single-cell RNA sequencing (scRNAseq). Compared to normal mouse BM, increased numbers of hematopoietic progenitors were found in the BM of mouse-rat chimeras. We also identified unique populations of hemangioblast-like progenitor cells expressing , and along with mesenchymal stromal cells expressing , and that were absent or ultra-rare in the normal mouse BM. In summary, by using rats as "bioreactors", we created a unique mouse BM cell transplant that contributes to multiple respiratory cell types after RILI. Interspecies chimeras have promise for future generations of BM transplants enriched in respiratory progenitor cells.

References
1.
Wu Y, Sun H, Qin L, Zhang X, Zhou H, Wang Y . Human amnion-derived mesenchymal stem cells attenuate acute lung injury in two different acute lung injury mice models. Front Pharmacol. 2023; 14:1149659. PMC: 10304826. DOI: 10.3389/fphar.2023.1149659. View

2.
Zhuang W, Lin Y, Su L, Wu M, Jeng H, Chang H . Mesenchymal stem/stromal cell-based therapy: mechanism, systemic safety and biodistribution for precision clinical applications. J Biomed Sci. 2021; 28(1):28. PMC: 8043779. DOI: 10.1186/s12929-021-00725-7. View

3.
Kolesnichenko O, Flood H, Zhang Y, Ustiyan V, Cuervo Jimenez H, Kalin T . Endothelial progenitor cells derived from embryonic stem cells prevent alveolar simplification in a murine model of bronchopulmonary dysplasia. Front Cell Dev Biol. 2023; 11:1209518. PMC: 10289167. DOI: 10.3389/fcell.2023.1209518. View

4.
Kalinichenko V, Lim L, Shin B, Costa R . Differential expression of forkhead box transcription factors following butylated hydroxytoluene lung injury. Am J Physiol Lung Cell Mol Physiol. 2001; 280(4):L695-704. DOI: 10.1152/ajplung.2001.280.4.L695. View

5.
Zhang Q, Xiang W, Yi D, Xue B, Wen W, Abdelmaksoud A . Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas. Stem Cell Res Ther. 2018; 9(1):228. PMC: 6109313. DOI: 10.1186/s13287-018-0977-z. View